PROM1 and mucoepidermoid carcinoma: Similarly, two studies reported CD133 expression in more than 84% [48] or 100% [38] of MEC cases, whereas another study utilizing two anti-CD133 antibodies derived from a different company reported staining in 0% or 13.3% of MEC cases [58].